Small Molecules
23 January 2014
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study23 January 2014
CytRx Initiates Phase 2 Clinical Trial with Aldoxorubicin for First-Line Treatment of AIDS-Related Kaposi’s Sarcoma23 January 2014
Starpharma Commences Dendrimer-Docetaxel Clinical Trial22 January 2014
Global Phase 3 Trial Commenced in Asia for Ixazomib, Takeda’s Oral Proteasome Inhibitor22 January 2014
EnVivo Pharmaceuticals Initiates COGNITIV AD, a Phase 3 Clinical Trial Program of Encenicline (EVP-6124) in Alzheimer’s Disease22 January 2014
Cortice Announces Enrollment of a Clinical Trial Targeting Tau Dysfunction in Mild-to-Moderate Alzheimer’s Disease22 January 2014
XIGDUO™ (dapagliflozin and metformin hydrochloride) approved in the European Union for type 2 diabetes21 January 2014
Roche provides update on the first two of six phase III studies of bitopertin in schizophrenia21 January 2014
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly21 January 2014
Preclinical Study Demonstrates Effect of Galectin Inhibitor on Serum Biomarker in Fatty Liver Disease With Fibrosis18 January 2014
First Patient Enrolled in Northern Hemisphere for Phase 3 Study of Favipiravir for Influenza17 January 2014
ArQule Provides Updates on Clinical Trials in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer with Tivantinib17 January 2014
Nuvo Research Announces FDA Approval of PENNSAID® 2%17 January 2014
Bayer Receives Approval for Riociguat in Japan for the Treatment of Chronic-Thromboembolic Pulmonary Hypertension16 January 2014
Resverlogix Announces Combined RVX-208 findings from SUSTAIN & ASSURE Phase 2b Trials16 January 2014
Merck Statement on FDA Advisory Committee for Vorapaxar, Merck’s Investigational Antiplatelet Medicine15 January 2014
Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome15 January 2014
Iroko Pharmaceuticals Announces Acceptance for Filing of ZORVOLEX™ sNDA for the Treatment of Osteoarthritis Pain in AdultsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports